fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Mixed results for new NHL therapies

Written by | 15 Jan 2018

Professor Stephen Ansell (Mayo Clinic, USA) speaks about harnessing the power of immunotherapy in Non Hodgkin’s Lymphoma.

ESCP Highlights 2017

Written by | 21 Oct 2017

ESCP 2017 delegates give their highlights, plus a report on the ESCP/ECCO symposium on ulcerative colitis and a focus on quality of life for patients with perianal Crohn’s disease.

ESCP 2017: Multidisciplinary decision-making for colectomy: the difficult patient 

Written by | 11 Oct 2017

By Maria Dalby (article) and Peter Mas Mollinedo (interviews) The decision to perform a colectomy in patients with ulcerative colitis (UC) should not be made lightly. Such a… read more.

ESCP 2017: Innovations in fistula management: stem cell therapy

Written by | 3 Oct 2017

By Maria Dalby (article) and Peter Mas Mollinedo (interviews) In an overview of the immunological rationale for, and clinical application of adipose-derived mesenchymal stem cell (MSC) therapies, Dr… read more.

ICML 2017: Response-adapted therapy for Hodgkin’s lymphoma

Written by | 30 Sep 2017

Professor Peter Johnson (Southampton, UK) tells us what’s new with response-adapted therapy and what are the benefits to patients.

ICML Highlights: Hot debates in Hodgkin Lymphoma

Written by | 9 Aug 2017

An entertaining case discussion session, chaired by Craig Moskowitz at ICML-14, highlighted some of the hot debates in Hodgkin lymphoma as discussed here by Professor Stephen Ansell (Rochester, USA),… read more.

ICML 2017: Highlights

Written by | 30 Jul 2017

Interviewer: Esther Drain Dr Toby Eyre (Oxford),  Professor Anas Younes (MSKCC, USA), Dr Andrew Davies (Southampton) and Dr Graham Collins (Oxford) discuss new data in CAR T cell therapy and the first EZH2 inhibitor, tazemetostat, in… read more.

ICML 2017: The role of stem cell transplantation for lymphoma in 2017

Written by | 11 Jul 2017

By Maria Dalby (article) and Esther Drain (interviews) Even in an era of rapid progress in terms of new agents and treatment approaches, stem cell transplantation (SCT) continues… read more.

ICML 2017: How will Hodgkins lymphoma be managed in 2020?

Written by | 11 Jul 2017

By Maria Dalby (article) and Esther Drain (interviews) Not only is the treatment ‘landscape’ in Hodgkin lymphoma (HL) changing rapidly both in the first-line and relapsed/refractory setting, but… read more.

Clinical trials vs real life

Written by | 15 Mar 2017

Dr Filip Baert (Roeselare, Belgium) gives a summary of his session on trial endpoints vs therapeutic objectives. he also discusses the role of ECCO in improving the data generated in… read more.

Predicting disease years before diagnosis

Written by | 15 Mar 2017

Predicting disease years before diagnosis is a passion for Professor Jean-Frederic Colombel (Icahn School of Medicine at Mount Sinai, NY, USA). Here he discusses 2 studies presented at… read more.

Managing Hodgkin lymphoma – a world view (from ISHL 2016)

Written by | 28 Nov 2016

by Christine Clark ISHL 2016 Professor Joseph Connors (Vancouver) speaks about the session at ISHL10 where a world view of the management of Hodgkin lymphoma was discussed. There… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.